The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Abstract
It is now clear that PCOS is often associated with profound insulin resistance as well as with defects in insulin secretion. These abnormalities, together with obesity, explain the substantially increased prevalence of glucose intolerance in PCOS. Moreover, since PCOS is an extremely common disorder, PCOS-related insulin resistance is an important cause of NIDDM in women (Table 3). The insulin resistance in at least 50% of PCOS women appears to be related to excessive serine phosphorylation of the insulin receptor. A factor extrinsic to the insulin receptor, presumably a serine/threonine kinase, causes this abnormality and is an example of an important new mechanism for human insulin resistance related to factors controlling insulin receptor signaling. Serine phosphorylation appears to modulate the activity of the key regulatory enzyme of androgen biosynthesis, P450c17. It is thus possible that a single defect produces both the insulin resistance and the hyperandrogenism in some PCOS women (Fig. 19). Recent studies strongly suggest that insulin is acting through its own receptor (rather than the IGF-I receptor) in PCOS to augment not only ovarian and adrenal steroidogenesis but also pituitary LH release. Indeed, the defect in insulin action appears to be selective, affecting glucose metabolism but not cell growth. Since PCOS usually has a menarchal age of onset, this makes it a particularly appropriate disorder in which to examine the ontogeny of defects in carbohydrate metabolism and for ascertaining large three-generation kindreds for positional cloning studies to identify NIDDM genes. Although the presence of lipid abnormalities, dysfibrinolysis, and insulin resistance would be predicted to place PCOS women at high risk for cardiovascular disease, appropriate prospective studies are necessary to directly assess this.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435 · cited 26×
“The dose-response curves for IGF-I were similar to those for insulin (data not shown).”
BackgroundInfluentialGenetic dissection of complex traits: guidelines for interpreting and reporting linkage results
Lander, E., & Kruglyak, L. (1995) · Nature Genetics · doi:10.1038/ng1195-241 · Cited by 5,239
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Genetic Dissection of Complex Traits
Lander, E. S., & Schork, N. J. (1994) · Science · doi:10.1126/science.8091226 · Cited by 3,413
Oncogenes and signal transduction
Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., & Soltoff, S. (1991) · Cell · doi:10.1016/0092-8674(91)90639-g · Cited by 2,694
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Research works printed but not linked: 16
- Dunaif, 1992, Blackwell Scientific
- Dunaif, 1988, Insulin resistance and hyperandrogenism: clinical syndromes and possible mechanisms, In: Pancheri P, Zichella L (eds) Biorhythms and Stress in the Physiopathology of Reproduction. Hemisphere Publishing Co, Washington, DC, pp, 293
- Crowley, 1996, New tools for pituitary-gonadal assessment, In: Filicori M, Flagmini C (eds) The Ovary: Regulation, Dysfunction and Treatment. Elsevier, Amsterdam, pp, 287
- Achard, 1921, Le virilisme pilaire et son association a l’insuffisance glycolytique (diabete des femmes a barb)., Bull Acad Natl Med, 86, 51
- Kierland, 1947, Acanthosis nigricans: An analysis of data in twenty-two cases and a study of its frequency in necropsy material., J Invest Dermatol, 9, 299, 10.1038/jid.1947.102 · doi:10.1038/jid.1947.102
- Colle, 1979, Acanthosis nigricans, hirsutisme et diabete insulin-resistant., Arch Fr Pediatr, 36, 518
- Mechanick, 1990, Masculinization: a clinical approach to the diagnosis and treatment of hyperandrogenic women, In: Mazzaferri E (ed) Advances in Endocrinology and Metabolism. Mosley Year Book, Inc, Chicago, IL, pp, 129
- Fadden, 1995, Quantitative and selective fluorophore labeling of phosphoserine on peptides and proteins: characterization at the attomole level by capillary electrophoresis and laser-induced fluorescence., Anal Biochem, 225, 81, 10.1006/abio.1995.1111 · doi:10.1006/abio.1995.1111
- Dunaif, 1997, Diamanti E Defective insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
- Diamond, 1985, Human follicular fluid insulin concentrations., J Clin Endocrinol Metab, 61, 990, 10.1210/jcem-61-5-990 · doi:10.1210/jcem-61-5-990
- Hintz, 1984, IGF-II binding on human lymphoid cells: demonstration of a common high affinity receptor for insulin like peptides., Biochem Biophys Res Commun, 118, 774, 10.1016/0006-291X(84)91462-1 · doi:10.1016/0006-291x(84)91462-1
- Erickson, 1995, The ovarian connection, In: Adashi EY, Rock JA, Rosenwaks Z (eds) Reproductive Endocrinology, Surgery, and Technology. Raven Press, New York, pp, 1141
- Mason, 1996, Insulin-like growth factor (IGF) I and II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries., J Clin Endocrinol Metab, 81, 276
- Dunaif, 1996, Book C-B Selective intrinsic defects in insulin and IGF-1 action in polycystic ovary syndrome (PCOS) in skin fibroblasts
- Dunaif, 1996, The insulin sensitizing agent troglitazone: a novel therapy for the polycystic ovary syndrome., J Clin Endocrinol Metab, 81, 3299
- Gharani, J Clin Endocrinol Metab, 81, 4174
Cited by
Items 201–272 of 272
The effect of polycystic ovary syndrome on health-related quality of life
Coffey, S., & Mason, H. (2003) · Gynecological Endocrinology · doi:10.1080/09513590312331290268 · Cited by 94
Wen, Q., Hu, M., Lai, M., Li, J., Hu, Z., Quan, K., Liu, J., Liu, H., Meng, Y., Wang, S., et al. (2022) · Human Reproduction · doi:10.1093/humrep/deab272 · Cited by 93
MENSTRUAL DISORDERS IN ADOLESCENTS
Gordon, C. M. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70135-8 · Cited by 92
Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis
Al Khalifah, R. A., Florez, I. D., Dennis, B., Thabane, L., & Bassilious, E. (2016) · PEDIATRICS · doi:10.1542/peds.2015-4089 · Cited by 91
Phelan, N., O’Connor, A., Kyaw Tun, T., Correia, N., Boran, G., Roche, H. M., & Gibney, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005538 · Cited by 89
Aromatase inhibitors in ovulation induction
(2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-823028 · Cited by 87
Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?
Muscogiuri, G., Policola, C., Prioletta, A., Sorice, G., Mezza, T., Lassandro, A., Della Casa, S., Pontecorvi, A., & Giaccari, A. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.12.010 · Cited by 86
Fux Otta, C., Wior, M., Iraci, G. S., Kaplan, R., Torres, D., Gaido, M. I., & Wyse, E. P. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903215581 · Cited by 85
Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome
Hahn, S., Kuehnel, W., Tan, S., Kramer, K., Schmidt, M., Roesler, S., Kimmig, R., Mann, K., & Janssen, O. E. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.031 · Cited by 82
“By fulfilling the NIH criteria, all women also fulfilled the 2003 Rotter- dam criteria (4).”
BackgroundInfluentialMisso, M. L., Costello, M. F., Garrubba, M., Wong, J., Hart, R., Rombauts, L., Melder, A. M., Norman, R. J., & Teede, H. J. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms036 · Cited by 81
Escobar-Morreale, H., Asuncion, M., Calvo, R., Sancho, J., & San Millan, J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450619 · Cited by 81
“Insulin resistance, resulting in compensatory hyperinsulinism and reduced SHBG levels, is central to the development of PCOS ( 21 ).”
BackgroundThe polycystic ovary syndrome: an update on metabolic and hormonal mechanisms.
(2015) · PubMed Central · Cited by 81
Georgopoulos, N. A., Saltamavros, A. D., Vervita, V., Karkoulias, K., Adonakis, G., Decavalas, G., Kourounis, G., Markou, K. B., & Kyriazopoulou, V. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.04.067 · Cited by 80
Environmental Control of Biological Rhythms: Effects on Development, Fertility and Metabolism
Amaral, F. G., Castrucci, A. M., Cipolla‐Neto, J., Poletini, M. O., Mendez, N., Richter, H. G., & Sellix, M. T. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12144 · Cited by 80
Moghrabi, N., Hughes, I. A., Dunaif, A., & Andersson, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5052 · Cited by 78
Self-citationSabuncu, T., Harma, M., Harma, M., Nazligul, Y., & Kilic, F. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)02162-9 · Cited by 78
Yilmaz, M., Biri, A., Karakoç, A., Törüner, F., Bingöl, B., Çakir, N., Tiras, B., Ayvaz, G., & Arslan, M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345339 · Cited by 77
Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity
Pasquali, R., Vicennati, V, Gambineri, A., & Pagotto, U. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.129 · Cited by 74
Günalan, E., Yaba, A., & Yılmaz, B. (2018) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2018.0077 · Cited by 74
Ezeh, U., Pall, M., Mathur, R., & Azziz, R. (2014) · Human Reproduction · doi:10.1093/humrep/deu096 · Cited by 71
Thomson, R. L., Buckley, J. D., & Brinkworth, G. D. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00758.x · Cited by 70
Tolino, A., Gambardella, V., Caccavale, C., D’Ettore, A., Giannotti, F., D’Antò, V., & De Falco, C. L. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.06.043 · Cited by 69
Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043140 · Cited by 69
“The clinical presentation of PCOS patients is influenced by other insulin related systemic effects through modulation of the luteinizing hormone pulse amplitude, stimulation of adrenal androgen secretion, and the suppression of hepatic sex hormone binding globulin production, which increases the amount of free testost…”
BackgroundAdam, J., Brandmaier, S., Leonhardt, J., Scheerer, M. F., Mohney, R. P., Xu, T., Bi, J., Rotter, M., Troll, M., Chi, S., et al. (2016) · Diabetes · doi:10.2337/db16-0512 · Cited by 68
A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries
Niafar, M., Pourafkari, L., Porhomayon, J., & Nader, N. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3976-7 · Cited by 66
Reproductive tissues maintain insulin sensitivity in diet-induced obesity
Wu, S., Divall, S., Wondisford, F., & Wolfe, A. (2012) · Diabetes · doi:10.2337/db11-0956 · Cited by 65
Moran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., Belobrajdic, D. P., & Norman, R. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2336 · Cited by 66
Reyes-Muñoz, E., Castellanos-Barroso, G., Ramírez-Eugenio, B. Y., Ortega-González, C., Parra, A., Castillo-Mora, A., & De la Jara-Díaz, J. F. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.023 · Cited by 61
Prenatal Exposure to Endocrine Disruptors: A Developmental Etiology for Polycystic Ovary Syndrome
Hewlett, M., Chow, E., Aschengrau, A., & Mahalingaiah, S. (2017) · Reproductive Sciences · doi:10.1177/1933719116654992 · Cited by 61
Romualdi, D., Giuliani, M., Cristello, F., Fulghesu, A. M., Selvaggi, L., Lanzone, A., & Guido, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.114 · Cited by 58
Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: Insight from animal models
Roland, A. V., & Moenter, S. M. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.002 · Cited by 57
De Leo, V., Morgante, G., Piomboni, P., Musacchio, M. C., Petraglia, F., & Cianci, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.137 · Cited by 56
Hyperinsulinaemic androgen excess in adolescent girls
Ibáñez, L., Ong, K. K., López-Bermejo, A., Dunger, D. B., & de Zegher, F. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.58 · Cited by 56
Insulin resistance in obesity: body-weight or energy balance?
Assali, A., Ganor, A., Beigel, Y., Shafer, Z., Hershcovici, T., & Fainaru, M. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1710293 · Cited by 55
Littlejohn, E. E., Weiss, R. E., Deplewski, D., Edidin, D. V., & Rosenfield, R. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.1.41 · Cited by 55
Altuntas, Y., Bilir, M., Ucak, S., & Gundogdu, S. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.07.038 · Cited by 54
Holte, J. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350784 · Cited by 52
Wu, J., Zhu, Y., Jiang, Y., & Cao, Y. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802217027 · Cited by 52
Use of metformin in the treatment of polycystic ovary syndrome
Genazzani, A. D., Ricchieri, F., & Lanzoni, C. (2010) · Women's Health · doi:10.2217/whe.10.43 · Cited by 51
van Dam, E. W. C. M., Roelfsema, F., Veldhuis, J. D., Hogendoorn, S., Westenberg, J., Helmerhorst, F. M., Frölich, M., Krans, H. M. J., Meinders, A. E., & Pijl, H. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00377.2003 · Cited by 51
“This finding implies that amelioration of metabolic anomalies, which are typical of PCOS (6), is not sufficient to restore menstrual cyclicity in all subjects.”
BackgroundPolak, A. M., Adamska, A., Krentowska, A., Łebkowska, A., Hryniewicka, J., Adamski, M., & Kowalska, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030732 · Cited by 48
Toscani, M. K., Mario, F. M., Radavelli-Bagatini, S., & Spritzer, P. M. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.01.009 · Cited by 47
“Abdominal obesity is found in most of these women in association with metabolic disturbances [3-5,7,8], whereas insulin resistance may occur independently of body mass index (BMI), with an adverse impact on lipid profile and blood pressure (BP) [8-11].”
BackgroundPatel, R., & Shah, G. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1279597 · Cited by 47
Jensterle, M., Janez, A., Mlinar, B., Marc, J., Prezelj, J., & Pfeifer, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0857 · Cited by 47
“PCOS has been the recognition that IR accompanied by compensatory hyperinsulinemia is a key component in the pathogenesis of the syndrome ( 14 ).”
BackgroundHerriot, A. M., Whitcroft, S., & Jeanes, Y. (2008) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2008.00890.x · Cited by 46
Porchia, L. M., Hernandez-Garcia, S. C., Gonzalez-Mejia, M. E., & López-Bayghen, E. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.03.010 · Cited by 45
Tagliaferri, V., Romualdi, D., Immediata, V., De Cicco, S., Di Florio, C., Lanzone, A., & Guido, M. (2017) · Clinical Endocrinology · doi:10.1111/cen.13304 · Cited by 40
Qublan, H. S., Yannakoula, E. K., Al-Qudah, M. A., & El-Uri, F. I. (2007) · Saudi Medical Journal · doi:10.15537/1658-3175.4126 · Cited by 40
Guo, R., Zheng, H., Li, Q., Qiu, X., Zhang, J., & Cheng, Z. (2022) · Reproductive Biology · doi:10.1016/j.repbio.2021.100594 · Cited by 37
Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences
Kousta, E., Tolis, G., & Franks, S. (2005) · HORMONES · doi:10.14310/horm.2002.11151 · Cited by 35
Penaforte, F. R. O., Japur, C. C., Diez-Garcia, R. W., & Chiarello, P. G. (2011) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2010.01130.x · Cited by 35
“, 2007), this syndrome is also associated with several features of metabolic syndrome, such as obesity, abdominal obesity (Kirchengast & Huber, 2001) and insulin resistance (IR) (Dunaif et al., 1989; Dunaif, 1997).”
BackgroundAbdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome
Kalra, P., Bansal, B., Nag, P., Singh, J. K., Gupta, R. K., Kumar, S., Rathore, R. K. S., Bhatia, V., & Bhatia, E. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.037 · Cited by 37
Tsai, Y.-H., Wang, T.-W., Wei, H.-J., Hsu, C.-Y., Ho, H.-J., Chen, W.-H., Young, R., Liaw, C.-M., & Chao, J. C.-J. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512004369 · Cited by 34
BERRIA, R., GASTALDELLI, A., LUCIDI, S., BELFORT, R., DEFILIPPIS, E., EASTON, C., BRYTZKI, R., CUSI, K., JOVANOVIC, L., & DEFRONZO, R. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.03.014 · Cited by 33
Zhang, J., Ye, J., Tao, X., Lu, W., Chen, X., & Liu, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.971604 · Cited by 33
Weight management strategies for patients with PCOS: current perspectives
Ozgen Saydam, B., & Yildiz, B. O. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1896966 · Cited by 33
Skeletal muscle mitochondrial function in polycystic ovarian syndrome
Rabøl, R., Svendsen, P. F., Skovbro, M., Boushel, R., Schjerling, P., Nilas, L., Madsbad, S., & Dela, F. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0419 · Cited by 33
Atiomo, W., Read, A., Golding, M., Silcocks, P., Razali, N., Sarkar, S., Hardiman, P., & Thornton, J. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2009.05.001 · Cited by 28
Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome
Micic, D., Sumarac-Dumanovic, M., Kendereski, A., Cvijovic, G., Zoric, S., Pejkovic, D., Micic, J., Milic, N., Dieguez, C., & Casanueva, F. F. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03349222 · Cited by 28
Is prostate‐specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
Vural, B., Özkan, S., & Bodur, H. (2007) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2007.00507.x · Cited by 23
Metabolic effects of polycystic ovary syndrome in adolescents
Han, Y., Kim, H. S., Lee, H.-J., Oh, J.-Y., & Sung, Y.-A. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.3.136 · Cited by 22
Wang, F., Dou, P., Wei, W., & Liu, P. J. (2024) · Nutrition & Diabetes · doi:10.1038/s41387-024-00263-9 · Cited by 20
“These conditions affect ovarian function by inter-acting with gonadotropins, which results in the overproduction of ovarian androgen and prevents ovulation [6].”
BackgroundNahuis, M. J., Oude Lohuis, E. J., Bayram, N., Hompes, P. G. A., Oosterhuis, G. J. E., van der Veen, F., Mol, B. W. J., & van Wely, M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.09.004 · Cited by 18
Normal Metabolic Flexibility despite Insulin Resistance Women with Polycystic Ovary Syndrome
Adamska, A., Karczewska-Kupczewska, M., Nikolajuk, A., Otziomek, E., Górska, M., Kowalska, I., & Straczkowski, M. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0115 · Cited by 17
Coles, N., Bremer, K., Kives, S., Zhao, X., & Hamilton, J. (2016) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.06.004 · Cited by 16
Cardiometabolic risk in patients with polycystic ovary syndrome.
Ozegowska, K., & Pawelczyk, L. (2015) · Polish Gynaecology · doi:10.17772/gp/59131 · Cited by 15
(2012) · Europe PMC (PubMed Central) · Cited by 13
Kim, N., & Chun, S. (2021) · Clinical and Experimental Reproductive Medicine · doi:10.5653/cerm.2021.04553 · Cited by 10
“Common metabolic problems associated with PCOS are glucose intolerance, type 2 diabetes mellitus (T2DM), central obesity, insulin resistance, and hyperinsulinemia [1-6].”
BackgroundInfluentialHart, K., Barr, S., Reeves, S., Sharp, K., & Jeanes, Y. (2016) · Nutrition & Dietetics · doi:10.1111/1747-0080.12188 · Cited by 9
Wang, Y., Xiang, T., Xia, X., Zhang, H., Geng, S., Yang, G., Qiu, S., He, Y., Liu, R., Li, L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1010714 · Cited by 5
Adrenomedullin: possible predictor of insulin resistance in women with polycystic ovary syndrome.
(2012) · PubMed · doi:10.3275/7872 · Cited by 5
Polycystic Ovary Syndrome (PCOS): From Diagnosis to Treatment
Rani, R., Priyanka, P., Yadav, R., Bajal, N., Mandal, B. S., & Kumar, A. (2024) · International Journal of Environment, Agriculture and Biotechnology · doi:10.22161/ijeab.94.5 · Cited by 4
Metadata
- Authors
- Dunaif, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1997-12-01
- Volume
- 18
- Issue
- 6
- Pages
- 774-800
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2100211815
- Cited by
- 2,458
- References
- 274
- FWCI
- 35.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.